Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Does a positive Lyme antibody test prove active infection?

A positive Lyme antibody test indicates the immune system has recognized Borrelia antigens but does not, by itself, establish an active infection.

SupportedJune 19, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

A positive Lyme antibody test reflects immune recognition of Borrelia antigens from exposure or infection, though it does not prove active infection by itself.

laying out figure…
All 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states serologic tests detect host antibodies produced after exposure rather than directly detecting the bacterium. Because antibody responses can persist long after clearance and sometimes cross-react with other conditions, test results must be interpreted alongside clinical signs and exposure history to assess current infection status.

Verified conclusion

The interpretation of Lyme disease serology requires a clear distinction between immune recognition and bacterial presence. Scientific evidence confirms that a positive Lyme antibody test signifies the host's immune system has encountered and responded to Borrelia burgdorferi antigens, but this finding alone is insufficient to diagnose an active, ongoing infection.

Clinical and diagnostic evidence

Lyme disease diagnostics primarily utilize a standard two-tiered testing (STTT) algorithm, involving an initial Enzyme Immunoassay (EIA) followed by a Western Blot. This process detects the presence of host-produced antibodies (IgM and IgG) rather than the spirochete itself.

  • Persistence of antibodies: Research demonstrates that antibodies against Borrelia antigens, such as VlsE or C6 peptide, can persist for years following successful antibiotic treatment and the resolution of symptoms. Consequently, a positive test may represent immunological "scarring" from a past, cleared infection.
  • Predictive value: The positive predictive value (PPV) of a Lyme test depends heavily on pre-test probability. In individuals without characteristic clinical signs (e.g., erythema migrans, joint swelling) or known exposure in endemic areas, a positive result is more likely to be a false positive or a marker of prior exposure rather than a current infection.

Mechanistic explanations

The biology of the humoral immune response dictates the limitations of these tests:

  • Antigen recognition: Upon infection, B-cells recognize specific spirochetal proteins, including outer surface proteins (OspC) and internal flagellar proteins (p41). This triggers the maturation of plasma cells that secrete antibodies.
  • Memory response: Once the immune system is primed, memory B-cells maintain the ability to produce these antibodies long after the pathogen has been eradicated.
  • Cross-reactivity: Positive results can occasionally occur due to molecular mimicry, where the immune system reacts to similar antigens from other pathogens (e.g., syphilis, Epstein-Barr virus) or autoimmune factors (e.g., rheumatoid factor), leading to a positive test in the absence of Borrelia.

Bottom line

A positive Lyme antibody test indicates that the immune system has recognized Borrelia antigens, but because antibodies persist long-term and do not directly track bacterial load, the test cannot prove an active infection in isolation. Diagnosis must be based on a combination of laboratory results, clinical symptoms, and epidemiological risk factors.

References

  1. Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease — pmc.ncbi.nlm.nih.gov ↗
  2. Sensitive and Specific Serodiagnosis of Lyme Disease by Enzyme-Linked Immunosorbent Assay with a Peptide Based on an Immunodominant Conserved Region of Borrelia burgdorferi VlsE — pmc.ncbi.nlm.nih.gov ↗
  3. Serologic Diagnosis of Lyme Borreliosis by Using Enzyme-Linked Immunosorbent Assays with Recombinant Antigens — pmc.ncbi.nlm.nih.gov ↗
  4. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol — pmc.ncbi.nlm.nih.gov ↗
  5. Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease — pmc.ncbi.nlm.nih.gov ↗
  6. Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease — mdpi.com ↗
  7. A Review of the Centers for Disease Control and Prevention's Guidelines for the Clinical Laboratory Diagnosis of Lyme Disease. — pmc.ncbi.nlm.nih.gov ↗
  8. Laboratory diagnosis of Lyme disease: advances and challenges. — pmc.ncbi.nlm.nih.gov ↗
  9. Lyme disease: How reliable are serologic results? — pmc.ncbi.nlm.nih.gov ↗
  10. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. — academic.oup.com ↗
  11. Serological Follow-up of Patients with Erythema Migrans: Persistence of Antibody Response to Borrelia Burgdorferi in Lyme Disease Patients — journals.sagepub.com ↗
  12. Persistent Anti-Borrelia IgM Antibodies without Lyme Borreliosis in the Clinical and Immunological Context — pmc.ncbi.nlm.nih.gov ↗
  13. C6 Test as an Indicator of Therapy Outcome for Patients with Localized or Disseminated Lyme Borreliosis — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes low-normal vitamin D weaken immune resilience?→Plausible11 sourcesCan low zinc and low vitamin D constrain immune pathways while an optimal hs-CRP does not support active systemic inflammation?→